Dapagliflozin is an advanced medication that helps the kidneys remove glucose from the bloodstream through urine. It is an essential treatment for type 2 diabetes and has proven benefits for patients with heart failure and chronic kidney disease. Available in various trusted generic forms, it helps maintain long-term metabolic health. Our platform provides a secure way to find and purchase authentic medications containing Dapagliflozin.
Dapagliflozin belongs to a class of medicines called sodium-glucose co-transport-2 (SGL 2) inhibitors. It helps the body lower blood glucose by encouraging the kidneys to remove excess sugar through urine. This active ingredient is marketed in the UK mainly as the branded product Farxiga.
In the United Kingdom, dapagliflozin is available as the brand-named tablet Farxiga (10 mg or 25 mg). The same ingredient is also sold as generic dapagliflozin tablets, which may be prescribed under a pharmacist’s name. Both the branded and generic forms come as oral tablets that are taken once daily, with or without food. Farxiga is the most widely recognised product and is listed on the NHS formulary for the relevant indications.
These conditions are the ones for which dapagliflozin has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK. Doctors may sometimes consider it for related health issues, but any off-label use follows clinical judgement and local guidance.
Dapagliflozin blocks a protein in the kidneys that normally re-absorbs glucose back into the bloodstream. By inhibiting this transporter, more glucose is expelled in the urine, which lowers the amount of sugar circulating in the blood. The result is a gradual reduction in blood-glucose levels and, for heart-failure or kidney patients, a modest diuretic effect that eases fluid buildup.
Most people notice only mild, short-lasting effects. Typical complaints include:
These reactions usually resolve on their own and do not require medical intervention unless they persist.
Although rare, some reactions need urgent attention:
If any of these signs appear, seek emergency medical help immediately.
People with certain health concerns should discuss dapagliflozin with their prescriber before starting:
Pregnant or breastfeeding individuals are generally advised against using SGL 2 inhibitors unless a specialist deems it necessary.
Dapagliflozin can interact with several other drug groups:
Patients should check the specific interaction list on the medication’s patient information leaflet and speak to a pharmacist if they use over-the-counter products or herbal supplements.
Store dapagliflozin tablets in a dry place, below 30 °C, and keep them out of reach of children. The medication is intended for short-term or long-term use as directed by a prescriber, depending on the condition being managed. Because strengths and exact dosing differ between Farxiga and generic versions, always refer to the individual product’s information for precise guidance.
Remember that the details provided here give a general overview of the ingredient; for personalised instructions, consult the patient-information leaflet that accompanies each specific medication.
This article offers general educational information about dapagliflozin as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing dapagliflozin may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.
